Erratum: Cliinical manifestations of, diagnostic approach to, and treatment of neurolymphomatosis in the rituximab era (Blood Advances (2021) 5:5 (1379-1387) DOI: 10.1182/bloodadvances.2020003666)

A. Khurana, M. Novo, G. S. Nowakowski

Research output: Contribution to journalComment/debatepeer-review

Abstract

In Figure 4 on page 1385, the color key in the upper right corner of each panel was incorrect. "No Rituximab" should be red, and "Rituximab" should be blue. The corrected figure is shown below. The publisher apologizes for the error, which has been corrected in the published article. (Figure Presented).

Original languageEnglish (US)
Pages (from-to)2053
Number of pages1
JournalBlood Advances
Volume5
Issue number7
DOIs
StatePublished - 2021

ASJC Scopus subject areas

  • Hematology

Fingerprint

Dive into the research topics of 'Erratum: Cliinical manifestations of, diagnostic approach to, and treatment of neurolymphomatosis in the rituximab era (Blood Advances (2021) 5:5 (1379-1387) DOI: 10.1182/bloodadvances.2020003666)'. Together they form a unique fingerprint.

Cite this